MEPSGEN

Micro Engineered
Physiological Systems Guiding and Enabling
the Next

Microengineered Human Organ Model Chips for Advanced Pharmaceutical Development
MORE

: What’s New

PIPELINE

Brochure : MEPS-X series

Brochure
More

TECHNOLOGY

Innovative platforms for drug development

: HUMAN ORGAN-ON-A-CHIP

: BIOMIMETIC NANOPARTICLE

: NANOPARTICLE
MANUFACTURING

MG-X series

MEPS-X series

PIPELINE

MG-X series

Lipid nanoparticle drug delivery system mass produced by microfluidic mixing technology

MEPS-X series

3D multi-structure tissue chip platform manufactured by high-precision injection molding process

: MEPSGEN, developing new medicines using human organs-on-chips technology
2023.02.13

: YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'
2023.02.08

: Online seminar : 'Microphysiological Barrier System for Drug Development'
2023.02.06

: 2022 13th Korean Tissue Engineering and Regenerative Medicine Society.
2022.12.09

: MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.
2022.11.02

: [1st block of Bio] Sharing the interview of Robert Langer, MIT professor.
2022.10.24

: Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery
2022.10.20

: MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.
2022.09.02

: Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.
2022.08.02

Micro Engineered
Physiological Systems Guiding and Enabling
the Next

TECHNOLOGY

PIPELINE

MEDIA

MEPSGEN, developing new medicines using human organs-on-chips technology

YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'

Online seminar : 'Microphysiological Barrier System for Drug Development'

2022 13th Korean Tissue Engineering and Regenerative Medicine Society.

MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.

[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.

Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery

MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.

Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.

Sitemap

Micro Engineered Physiological Systems Guiding and Enabling the Next

TECHNOLOGY

PIPELINE

MEDIA

MEPSGEN, developing new medicines using human organs-on-chips technology

YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'

Online seminar : 'Microphysiological Barrier System for Drug Development'

2022 13th Korean Tissue Engineering and Regenerative Medicine Society.

MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.

[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.

Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery

MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.

Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.

Sitemap

Micro Engineered
Physiological Systems Guiding and Enabling
the Next